Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALNSE - FR0004065639 - Common Stock

38.9 EUR
+0.5 (+1.3%)
Last: 1/5/2026, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ALNSE. ALNSE was compared to 47 industry peers in the Aerospace & Defense industry. ALNSE has a great financial health rating, but its profitability evaluates not so good. ALNSE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ALNSE had positive earnings in the past year.
In the past year ALNSE had a positive cash flow from operations.
Each year in the past 5 years ALNSE has been profitable.
Of the past 5 years ALNSE 4 years had a positive operating cash flow.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

ALNSE has a Return On Assets of 2.11%. This is in the lower half of the industry: ALNSE underperforms 63.83% of its industry peers.
The Return On Equity of ALNSE (4.58%) is worse than 70.21% of its industry peers.
The Return On Invested Capital of ALNSE (7.73%) is comparable to the rest of the industry.
ALNSE had an Average Return On Invested Capital over the past 3 years of 9.24%. This is in line with the industry average of 9.17%.
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROIC 7.73%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

ALNSE has a worse Profit Margin (2.09%) than 68.09% of its industry peers.
ALNSE's Profit Margin has declined in the last couple of years.
The Operating Margin of ALNSE (5.38%) is worse than 72.34% of its industry peers.
ALNSE's Operating Margin has declined in the last couple of years.
ALNSE has a Gross Margin of 45.65%. This is in the better half of the industry: ALNSE outperforms 72.34% of its industry peers.
In the last couple of years the Gross Margin of ALNSE has declined.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

ALNSE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ALNSE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALNSE has more shares outstanding
Compared to 1 year ago, ALNSE has an improved debt to assets ratio.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.61 indicates that ALNSE is not in any danger for bankruptcy at the moment.
ALNSE has a Altman-Z score of 3.61. This is in the better half of the industry: ALNSE outperforms 76.60% of its industry peers.
The Debt to FCF ratio of ALNSE is 1.73, which is an excellent value as it means it would take ALNSE, only 1.73 years of fcf income to pay off all of its debts.
ALNSE has a Debt to FCF ratio of 1.73. This is amongst the best in the industry. ALNSE outperforms 82.98% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that ALNSE is not too dependend on debt financing.
ALNSE's Debt to Equity ratio of 0.10 is amongst the best of the industry. ALNSE outperforms 91.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Altman-Z 3.61
ROIC/WACC0.92
WACC8.39%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.70 indicates that ALNSE should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.70, ALNSE belongs to the best of the industry, outperforming 82.98% of the companies in the same industry.
A Quick Ratio of 1.33 indicates that ALNSE should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.33, ALNSE belongs to the top of the industry, outperforming 82.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.33
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The earnings per share for ALNSE have decreased strongly by -58.66% in the last year.
ALNSE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.31% yearly.
ALNSE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.20%.
ALNSE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)-58.66%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%

3.2 Future

The Earnings Per Share is expected to grow by 35.88% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALNSE will show a very strong growth in Revenue. The Revenue will grow by 32.29% on average per year.
EPS Next Y36.08%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 59.85, the valuation of ALNSE can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ALNSE is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 26.87, ALNSE is valued quite expensively.
The Price/Forward Earnings ratio is 12.14, which indicates a correct valuation of ALNSE.
97.87% of the companies in the same industry are more expensive than ALNSE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.46. ALNSE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 59.85
Fwd PE 12.14
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

ALNSE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALNSE is cheaper than 82.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALNSE is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 34.59
EV/EBITDA 12.98
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ALNSE's earnings are expected to grow with 35.88% in the coming years.
PEG (NY)1.66
PEG (5Y)N/A
EPS Next 2Y46.2%
EPS Next 3Y35.88%

4

5. Dividend

5.1 Amount

ALNSE has a yearly dividend return of 0.70%, which is pretty low.
Compared to an average industry Dividend Yield of 0.87, ALNSE has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, ALNSE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

The dividend of ALNSE is nicely growing with an annual growth rate of 22.60%!
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

ALNSE pays out 41.18% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ALNSE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP41.18%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (1/5/2026, 7:00:00 PM)

38.9

+0.5 (+1.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-23 2025-07-23
Earnings (Next)N/A N/A
Inst Owners22.43%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap131.48M
Revenue(TTM)99.97M
Net Income(TTM)2.09M
Analysts86.67
Price Target65.28 (67.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP41.18%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 59.85
Fwd PE 12.14
P/S 1.32
P/FCF 34.59
P/OCF 17.25
P/B 2.88
P/tB 3.25
EV/EBITDA 12.98
EPS(TTM)0.65
EY1.67%
EPS(NY)3.2
Fwd EY8.23%
FCF(TTM)1.12
FCFY2.89%
OCF(TTM)2.26
OCFY5.8%
SpS29.58
BVpS13.52
TBVpS11.96
PEG (NY)1.66
PEG (5Y)N/A
Graham Number14.06
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROCE 10.31%
ROIC 7.73%
ROICexc 10.37%
ROICexgc 12%
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
FCFM 3.8%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexgc growth 3Y-2.2%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Debt/EBITDA 0.52
Cap/Depr 108.86%
Cap/Sales 3.82%
Interest Coverage 29.25
Cash Conversion 85.72%
Profit Quality 181.61%
Current Ratio 1.7
Quick Ratio 1.33
Altman-Z 3.61
F-Score5
WACC8.39%
ROIC/WACC0.92
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.66%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
EPS Next Y36.08%
EPS Next 2Y46.2%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%
Revenue Next Year33.7%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-23.13%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3Y55.39%
EBIT Next 5YN/A
FCF growth 1Y26.15%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y22.28%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%

NSE / ALNSE.PA FAQ

What is the fundamental rating for ALNSE stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALNSE.PA.


Can you provide the valuation status for NSE?

ChartMill assigns a valuation rating of 5 / 10 to NSE (ALNSE.PA). This can be considered as Fairly Valued.


How profitable is NSE (ALNSE.PA) stock?

NSE (ALNSE.PA) has a profitability rating of 3 / 10.


What is the valuation of NSE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NSE (ALNSE.PA) is 59.85 and the Price/Book (PB) ratio is 2.88.


Can you provide the financial health for ALNSE stock?

The financial health rating of NSE (ALNSE.PA) is 8 / 10.